PTCA Balloons Pipeline Review, 2015 - Extensive Coverage of the PTCA Balloon Products Under Development
M2 - Mon Aug 17, 2:31AM CDT
Research and Markets (http://www.researchandmarkets.com/research/pgbb35/ptca_balloons) has announced the addition of the "PTCA Balloons - Pipeline Review, 2015" report to their offering. PTCA Balloons - Pipeline Review, 2015 Summary Our Medical Devices sector report, PTCA Balloons - Pipeline Review, 2015" provides an overview of PTCA Balloon products currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key PTCA Balloon pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by Our team of industry experts. Scope - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of PTCA Balloon products and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 List of Tables and List of Figures 2 Introduction 3 Products under Development 4 PTCA Balloons - Pipeline Products under Development by Companies 5 PTCA Balloons Companies and Product Overview 6 PTCA Balloons- Recent Developments 7 Appendix Companies Mentioned - Acrostak (Schweiz) AG - Andramed GmbH - CID S.r.l. - Innovia LLC - Meril Life Sciences Pvt. Ltd. - MicroPort Scientific Corporation - Pressure Products, Inc. - Terumo Corporation - VasoTech Inc. For more information visit http://www.researchandmarkets.com/research/pg...a_balloons
Insulin Delivery Pipeline Review 2015 - Extensive Coverage of the Insulin Delivery Products Under Development
M2 - Fri Aug 14, 8:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/8ffvgt/insulin_delivery) has announced the addition of the "Insulin Delivery - Pipeline Review, 2015" report to their offering. Summary This Medical Devices sector report, Insulin Delivery - Pipeline Review, 2015" provides an overview of Insulin Delivery currently in pipeline stage. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Insulin Delivery pipeline products. This report is prepared using data sourced from in-house databases, secondary and primary research by Our team of industry experts. Scope - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Insulin Delivery and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 List of Tables and List of Figures 2 Introduction 3 Products under Development 4 Insulin Delivery - Pipeline Products under Development by Companies 5 Insulin Delivery Companies and Product Overview 6 Insulin Delivery- Recent Developments 7 Appendix Companies Mentioned - Amrita Vishwa Vidyapeetham - Andain, Inc - AstraZeneca PLC - Becton, Dickinson and Company - Cellnovo Ltd. - CeQur SA - Companion Medical - ConvaTec Healthcare B S.a.r.l. - Dance Biopharm Inc. - Debiotech S.A. - InsuLenz - Insulet Corporation - InsuLine Medical Ltd. - LifeScan, Inc. - Medical International Technologies (Mit Canada) Inc. - MedSolve Technologies, Inc. - MicroPort Scientific Corporation - North Carolina State University - Sanofi - SFC Fluidics LLC - Spring Health Solutions Ltd. - Transdermal Specialties, Inc. - University of KwaZulu-Natal - University of Toronto - Ypsomed Holding AG For more information visit http://www.researchandmarkets.com/research/8f...n_delivery
PODD: 29.51 (+0.19), AZN: 32.23 (-0.16)
Global PTCA Balloon Catheter Market 2015-2019 - Increased Demand for Minimally Invasive Procedures
M2 - Thu Jul 30, 7:41AM CDT
Research and Markets (http://www.researchandmarkets.com/research/x6rt38/global_ptca) has announced the addition of the "Global PTCA Balloon Catheter Market 2015-2019" report to their offering. The global PTCA balloon catheter market to grow at a CAGR of 3.48% during 2014-2019. The report includes the present scenario and the growth prospects of the global PTCA balloon catheter market for 2015-2019. The market can be segmented into four divisions: normal balloon catheter, drug eluting balloon catheter, cutting balloon catheter, and scoring balloon catheter. To calculate the market size, we consider the revenue generated from these PTCA balloon catheters. The report covers the market landscape and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market. The elderly population worldwide is increasingly opting for minimally invasive surgeries. Advances in PTCA balloon catheters have led to an increased number of clinical trials and the launch of new products in the market. These procedures are performed through small incisions in the body and can be used to treat plaque obstructions in the arteries of the heart and other blood vessels of peripheral organs, such as the brain and kidneys. These procedures are advantageous over conventional surgical methods as they offer a short recovery time, low risk of infection, cost-effectiveness, reduced scars resulting in less physical trauma, minimized bleeding, and shorter hospital stays. According to the report, the high demand for minimally invasive procedures in interventional cardiology to treat CHDs and PVDs will likely contribute to market growth. These procedures are advantageous over conventional surgeries, have low risk, and leave fewer scars after the operation. Further, the report states that the increased use of self-expanding stents, which do not require balloon catheters, also limits market growth. Key Vendors - Abbott Laboratories - Boston Scientific - Medtronic - Terumo Other Prominent Vendors - Aachen Resonance - Acrostak - Alvimedica - AngioScore - Arthesys - Asahi Intecc - Atrium Medical - B. Braun Melsungen - Biosensors International - BIOTRONIK - C.R. Bard - Cook Medical - Cordis - MicroPort Scientific - Natec Medical - Smiths Medical - Terumo Medical - Tokai Medical Products - Volcano For more information visit http://www.researchandmarkets.com/research/x6...lobal_ptca
BSX: 16.88 (+0.09), ABT: 41.89 (+0.73), MDT: 72.60 (+0.55)
Research and Markets: India Coronary Stent and Angioplasty Market Through 2020 (Cath Lab Level Information - City, State and National)
Business Wire - Fri Jul 24, 8:04AM CDT
Research and Markets (http://www.researchandmarkets.com/research/gj92x9/india_coronary) has announced the addition of the "India Coronary Stent and Angioplasty Market Through 2020 (Cath Lab Level Information - City, State and National)" report to their offering. The coronary stent market in India, which comprises Drug Eluting Stent (DES), Bare Metal Stent (BMS) and Bio-Absorbable Stent (BVS), was valued above $400 million in 2012. DES accounts for bulk of sales in India. The bio-absorbable stent ABSORB has garnered a considerable traction despite its high cost compared with the other available DES. The key players operating in the segment are Alvimedica, Abbott Vascular, a division of Abbott Laboratories (NYSE : ABT), Boston Scientific (NYSE : BSX, LSE : BSX), Biosensors Inc., Biotronik, JW Medical, Medtronic, Inc. (NYSE :MDT), Meril Life Sciences, MicroPort Scientific Corporation (HKG: 0853), Sahajanand Medical Technologies and Translumina Therapeutics. The market has grown impressively supported by a rise in coronary angioplasties which has resulted from a surge in cardiovascular diseases (CVDs), augmented healthcare spending as well as an increase in number of interventional cardiologists and cath labs in government and private hospitals, including individual cath lab centres run by interventional cardiologists as well as new corporate hospitals. The demand has surged as central and state governments capped reimbursement rates which enhanced affordability resulting in an increase in volume. The decrease in reimbursement rates has given an edge to Indian, Asian and some of the Europe-based mid-sized MNCs which sell stents at almost half the price of those sold by US companies. In the US, the stents market has slumped significantly due to negative results from clinical studies suggesting that one-third of stent implants are unnecessary. However, in India these studies have not made an impact as most Indian cardiologists do not seem to have taken these clinical outcomes seriously. India Coronary Stent and Angioplasty Market Through 2020 (Cath Lab Level Information - City, State and National)', is a market report that reviews historical trends and forecasts (between 2007 and 2020), annualised sales, market size (value and units), market growth, pricing, competitive landscape and market share. The research report covers 700 cath labs across the country. It analyses angioplasty procedures' (PCI and PTCA) data for the country with a detailed analysis at national, state, district, city and hospital levels. It provides PCI data of 550 hospitals from more than 150 cities. Companies Mentioned - Abbott Vascular, a division of Abbott Laboratories - Alvimedica - Biosensors Inc. - Biotronik - Boston Scientific - JW Medical - Medtronic Inc. - Meril Life Sciences - MicroPort Scientific Corporation - Sahajanand Medical Technologies - Translumina Therapeutics For more information visit http://www.researchandmarkets.com/research/gj...a_coronary
BSX: 16.88 (+0.09), ABT: 41.89 (+0.73), MDT: 72.60 (+0.55)
India Coronary Stent and Angioplasty Market Through 2020 (Cath Lab Level Information - City, State and National)
M2 - Fri Jul 24, 6:22AM CDT
Research and Markets (http://www.researchandmarkets.com/research/rbwhb3/india_coronary) has announced the addition of the "India Coronary Stent and Angioplasty Market Through 2020 (Cath Lab Level Information - City, State and National)" report to their offering. The coronary stent market in India, which comprises Drug Eluting Stent (DES), Bare Metal Stent (BMS) and Bio-Absorbable Stent (BVS), was valued above $400 million in 2012. DES accounts for bulk of sales in India. The bio-absorbable stent ABSORB has garnered a considerable traction despite its high cost compared with the other available DES. The key players operating in the segment are Alvimedica, Abbott Vascular, a division of Abbott Laboratories (NYSE : ABT), Boston Scientific (NYSE : BSX, LSE : BSX), Biosensors Inc., Biotronik, JW Medical, Medtronic, Inc. (NYSE :MDT), Meril Life Sciences, MicroPort Scientific Corporation (HKG: 0853), Sahajanand Medical Technologies and Translumina Therapeutics. The market has grown impressively supported by a rise in coronary angioplasties which has resulted from a surge in cardiovascular diseases (CVDs), augmented healthcare spending as well as an increase in number of interventional cardiologists and cath labs in government and private hospitals, including individual cath lab centres run by interventional cardiologists as well as new corporate hospitals. The demand has surged as central and state governments capped reimbursement rates which enhanced affordability resulting in an increase in volume. The decrease in reimbursement rates has given an edge to Indian, Asian and some of the Europe-based mid-sized MNCs which sell stents at almost half the price of those sold by US companies. In the US, the stents market has slumped significantly due to negative results from clinical studies suggesting that one-third of stent implants are unnecessary. However, in India these studies have not made an impact as most Indian cardiologists do not seem to have taken these clinical outcomes seriously. India Coronary Stent and Angioplasty Market Through 2020 (Cath Lab Level Information - City, State and National)', is a market report that reviews historical trends and forecasts (between 2007 and 2020), annualised sales, market size (value and units), market growth, pricing, competitive landscape and market share. The research report covers 700 cath labs across the country. It analyses angioplasty procedures' (PCI and PTCA) data for the country with a detailed analysis at national, state, district, city and hospital levels. It provides PCI data of 550 hospitals from more than 150 cities. Companies Mentioned - Abbott Vascular, a division of Abbott Laboratories - Alvimedica - Biosensors Inc. - Biotronik - Boston Scientific - JW Medical - Medtronic Inc. - Meril Life Sciences - MicroPort Scientific Corporation - Sahajanand Medical Technologies - Translumina Therapeutics For more information visit http://www.researchandmarkets.com/research/rb...a_coronary
BSX: 16.88 (+0.09), ABT: 41.89 (+0.73), MDT: 72.60 (+0.55)
Global Coronary Guidewires Pipeline Report 2015
M2 - Wed Jul 22, 3:44AM CDT
Research and Markets (http://www.researchandmarkets.com/research/5jnt7x/coronary) has announced the addition of the "Coronary Guidewires - Pipeline Review, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Coronary Guidewires pipeline products. Scope - Extensive coverage of the Coronary Guidewires under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Coronary Guidewires and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Products under Development 4 Coronary Guidewires - Pipeline Products under Development by Companies 5 Coronary Guidewires Companies and Product Overview 6 Coronary Guidewires- Recent Developments 7 Appendix Companies Mentioned - Boston Scientific Corporation - Computer Vision Systems Laboratories Corp. - Guided Interventions LLC - MaRVis Technologies GmbH - MicroPort Scientific Corporation - Occlutech International AB - Opsens Inc. - The Cleveland Clinic Foundation For more information visit http://www.researchandmarkets.com/research/5jnt7x/coronary
BSX: 16.88 (+0.09)
Spinal Fusion - Pipeline Review, 2015
M2 - Fri Jun 26, 3:56AM CDT
Research and Markets (http://www.researchandmarkets.com/research/26cwc3/spinal_fusion) has announced the addition of the "Spinal Fusion - Pipeline Review, 2015" report to their offering. The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key spinal fusion pipeline products. Scope - Extensive coverage of the Spinal Fusion products under development - The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities - The report reviews the major players involved in the development of Spinal Fusion and list all their pipeline projects - The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage - The report provides key clinical trial data of ongoing trials specific to pipeline products - Recent developments in the segment / industry Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Products under Development 4 Spinal Fusion - Pipeline Products under Development by Companies 5 Spinal Fusion Companies and Product Overview 6 Spinal Fusion - Recent Developments 7 Appendix Companies Featured: - 4-Web Spine, LLC - Alphatec Holdings, Inc. - Amedica Corporation - APTO Orthopaedics - Aurora Spine Corporation - Bio2 Technologies, Inc. - Bonovo Orthopedics, Inc. - Cortical Concepts (Inactive) - DiFusion Technologies Inc. - ECA Medical Instruments, Inc. - Eden Spine, LLC - Eminent Spine, LLC - Exactech, Inc. - Expanding Orthopedics Inc. - Globus Medical, Inc. - H. Lee Moffitt Cancer Center & Research Institute, Inc. - Implants International Limited - Integra LifeSciences Holdings Corporation - Intelligent Implant Systems, LLC - Intrinsic Therapeutics, Inc. - Jemo Spine, LLC. - Kspine, Inc. - Medtronic plc - MicroPort Scientific Corporation - Nasseo, Inc. - NLT SPINE - NuVasive, Inc. - OsteoGeneX Inc. - OsteoVantage, Inc. - Paradigm Spine, LLC For more information visit http://www.researchandmarkets.com/research/26...nal_fusion
ATEC: 0.34 (-0.02), MDT: 72.60 (+0.55), IARTV: 65.00 (-37.45), GMED: 22.68 (+0.22), EXAC: 18.68 (-0.10), NUVA: 50.96 (-0.21), AMDA: 0.30 (-0.02)
Electrophysiology Market by Product, Ablation Catheter, Lab Devices & Indication - Global Forecasts to 2019
M2 - Tue Jun 02, 4:09AM CDT
Research and Markets (http://www.researchandmarkets.com/research/tkzjjk/electrophysiology) has announced the addition of the "Electrophysiology Market by Product {Diagnostic Catheter (Conventional, Advanced, Ultrasound)), Ablation Catheter (Cryoablation, RF, Microwave), Lab Devices (Mapping, Recording, Generator, ICE, X-ray)) & Indication (AF, VT, WPW) - Global Forecasts to 2019" report to their offering. The global electrophysiology (EP) market is estimated to grow at a significant CAGR of 10.3% from 2014 to 2019 Although mature markets such as the U.S., Germany, Japan, and the U.K. held larger shares in the electrophysiology market in 2014, the emerging countries in the Asia-Pacific market are poised to grow at higher rate in the next five years. Factors such as rapidly increasing aging population, growing focus of multinational companies on emerging markets, improving and modernizing healthcare infrastructure, and growing number of EP labs are propelling the growth of market in these countries. The global electrophysiology market growth is driven by the development of technologically advanced electrophysiology devices, rapid growth in aging population with high risk of target diseases, increasing incidence of arrhythmia cases across the globe, growing focus of key market players to expand their geographic presence, and increasing demand of catheter ablation procedures. However, lack of skilled and experienced electrophysiologists in developing nations and unfavorable healthcare reforms in the U.S. are restraining the growth of this market. In this report, the global electrophysiology market has been segmented on the basis of products and indications. On the basis of products, the electrophysiology (EP) market is categorized into EP diagnostic catheters, EP ablation catheters, and EP laboratory devices. The EP diagnostic catheters segment is further divided into conventional EP diagnostic catheters, advanced EP diagnostic catheters, and ultrasound EP diagnostic catheters. The EP ablation catheters segment is further classified into radiofrequency (RF) EP ablation catheters, cryoablation EP catheters, laser ablation systems, navigational advanced mapping accessories, and microwave ablation. The EP laboratory devices segment is categorized into X-ray systems, 3D mapping systems, EP recording systems, remote steering systems, intracardiac echocardiography systems (ICE), and radiofrequency (RF) ablation generators. On the basis of indication, the electrophysiology market is divided into atrial fibrillation, ventricular fibrillation, ventricular tachycardia, atrial tachycardia, atrial flutter, Wolff-Parkinson-White (WPW) syndrome, and atrioventricular nodal reentry tachycardia. Key Topics Covered: 1 Introduction 2 Research Methodology 3 Executive Summary 4 Premium Insights 5 Market Overview 6 Industry Insights 7 Electrophysiology Market, By Product 8 Electrophysiology Market, By Indication 9 Electrophysiology Market, By Region 10 Competitive Landscape 11 Company Profiles - Abbott Laboratories - Biosense Webster, Inc. - Biotronik Se & Co. KG. - Boston Scientific Corporation - GE Healthcare - Koninklijke Philips N.V. - Medtronic, Inc. - Microport Scientific Corporation - Siemens AG - St. Jude Medical, Inc. For more information visit http://www.researchandmarkets.com/research/tk...physiology
BSX: 16.88 (+0.09), ABT: 41.89 (+0.73), MDT: 72.60 (+0.55), STJ: 63.99 (+0.80)
China Orthopedic Instrument Industry Report, 2014-2017
PR Newswire - Thu May 21, 11:11AM CDT
Benefiting from accelerated aging population and rising proportion of reimbursement for medical expenses, the Chinese orthopedic instrument market demand has been effectively released, with its scale presenting a CAGR of 19.2% during 2009-2013. Trauma products, spine products and joint products are three product segments of orthopedic instruments in China, of which trauma products holding the bulk with 36.9% market share in 2013.
MDT: 72.60 (+0.55), SYK: 97.75 (+0.40)
Intracranial Stents - 2015-2020 Global Strategic Business Report: Medical Tourism Buoys Demand for Stenting Procedures in Emerging Nations
M2 - Tue Mar 31, 6:17AM CDT
Research and Markets (http://www.researchandmarkets.com/research/24lv7t/intracranial) has announced the addition of the "Intracranial Stents - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Intracranial Stents in US$ Thousands. The report provides separate comprehensive analytics for the US, Europe, and Rest of World. Annual estimates and forecasts are provided for the period 2013 through 2020. Also, a seven-year historic analysis is provided for these markets. Market data and analytics are derived from primary and secondary research. Company profiles are primarily based on public domain information including company URLs. The report profiles 14 companies including many key and niche players such as: - Admedes Schuessler GmbH (Germany) - BALT Extrusion (France) - Cardiatis SA (Belgium) - Codman & Shurtleff, Inc. (US) - Covidien PLC (Ireland) - ITGI Medical Ltd. (Israel) - MicroPort Scientific Corporation (China) - OBEX Medical (New Zealand) - Stryker Corp. (US) Key Topics Covered: 1. INDUSTRY OVERVIEW 2. INTRACRANIAL STENTS AVAILABLE IN THE MARKET 3. MARKET DRIVERS & TRENDS 4. PRODUCT OVERVIEW 5. NEUROVASCULAR DISEASES - AN OVERVIEW 6. MAJOR NEUROVASCULAR INDICATIONS REQUIRING STENTING PROCEDURES 7. PRODUCT INTRODUCTIONS & APPROVALS 8. RECENT INDUSTRY ACTIVITY 9. FOCUS ON SELECT PLAYERS 10. GLOBAL MARKET PERSPECTIVE Total Companies Profiled: 14 (including Divisions/Subsidiaries - 17) - The United States (6) - Europe (6) - - France (1) - - Germany (3) - - Rest of Europe (2) - Asia-Pacific (Excluding Japan) (4) - Middle East (1) For more information visit http://www.researchandmarkets.com/research/24...tracranial
SYK: 97.75 (+0.40)
MediPoint: Coronary Stents - South America Analysis and Market Forecasts to 2020
M2 - Wed Mar 25, 6:07AM CDT
Research and Markets (http://www.researchandmarkets.com/research/lz276h/medipoint) has announced the addition of the "MediPoint: Coronary Stents - SA Analysis and Market Forecasts" report to their offering. The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes. Minimally-invasive techniques such as stenting have been widely adopted in Brazil. The coronary stents market will be driven by the rising prevalence of CAD, the growing aging population, and the potential cost savings associated with DES technologies. Scope - An overview of Coronary Stents, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the SA Coronary Stents market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Coronary Stents. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Coronary Stents sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Products 9 Clinical Trial Analysis 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned - Abbott Vascular - Boston Scientific Corporation - Medtronic - Alvimedica - Amaranth Medical - amg International - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Cardionovum - C.R. Bard - Elixir Medical Corporation - eucatech AG - Hexacath - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MicroPort Scientific Corporation - Minvasys - MIV Therapeutics - Opto Circuits - OrbusNeich Medical - Relisys Medical Devices - Sahajanand Medical Technologies - Terumo Corporation - Translumina - Vascular Concepts For more information visit http://www.researchandmarkets.com/research/lz276h/medipoint
BSX: 16.88 (+0.09), MDT: 72.60 (+0.55)
MediPoint: Coronary Stents - APAC Analysis and Market Forecasts to 2020
M2 - Wed Mar 25, 5:47AM CDT
Research and Markets (http://www.researchandmarkets.com/research/qvwjmw/medipoint) has announced the addition of the "MediPoint: Coronary Stents - APAC Analysis and Market Forecasts" report to their offering. The APAC countries have diverse populations, ethnicities, and clinical practices. Many of the developed economies in these regions have a growing aging population, given the improvements made in healthcare (Cheng, 2010). Japan is one of the largest markets for cardiovascular devices in the world due to its advanced healthcare system and high pricing. In 2013, Among the emerging markets, which include Brazil, China, and India, China has the largest share in the coronary stents market for treating CAD. Scope - An overview of Coronary Stents, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the APAC Coronary Stents market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Coronary Stents. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Coronary Stents sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Products 9 Clinical Trial Analysis 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned - Abbott Vascular - Boston Scientific Corporation - Medtronic - Alvimedica - Amaranth Medical - amg International - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Cardionovum - C.R. Bard - Elixir Medical Corporation - eucatech AG - Hexacath - IRAMED - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MicroPort Scientific Corporation - Minvasys - MIV Therapeutics - Opto Circuits - OrbusNeich Medical - Relisys Medical Devices - REVA Medical - Sahajanand Medical Technologies - STENTYS For more information visit http://www.researchandmarkets.com/research/qvwjmw/medipoint
BSX: 16.88 (+0.09), MDT: 72.60 (+0.55)
Global Coronary Stents Market Outlook Report 2015 - Analysis and Forecasts 2007-2020
M2 - Thu Mar 19, 6:39AM CDT
Research and Markets (http://www.researchandmarkets.com/research/jfw4v9/global_coronary) has announced the addition of the "Global Coronary Stents Market Outlook, 2007 - 2020" report to their offering. The global coronary stent market is expected grow, despite the current downward trend in the US, the largest market, and declining selling prices globally. The market study takes into account various global clinical studies and pipeline products and it suggests that the coronary stent pipeline is clustered with new generation Drug Eluting Stent (DES), bioactive stents, bioabsorbable technology and stents for the niche segments such as complex and bifurcated vessels. Altering the trend, small to medium size companies from the developing economies are ambitiously conducting clinical studies to win the approvals and expand the use of devices for new indications. The stent market globally and in the developed nations is largely controlled by three playersAbbott Laboratories, Boston Scientific, and Medtronic. While in developing economies, small and medium players from Asia and Europe have a considerable share in terms of volume. This comprehensive, 465 page global strategic business report is authored by team of sector analysts who used rigorous primary and secondary research, robust analytical model to provide strategic insight and to forecast in for all major stent types BMS, DES, Bioabsorbable stents in leading 23 geographies. Key Topics Covered: 1. Charts & Tables 2. Executive Summary 3. Market at a Glance 4. Introduction to Stents 5. Coronary Stents 6. Types of Stents 7. Approvals 8. Competitive Landscape 9. Clinical Studies 10. Coronary Stents - Market Drivers and Restrains 11. Overview: Market trends 12. Approvals Driving the Growth 13. Market Data 14. Company Profiles 15. Recent Events 16. Appendix Companies Mentioned - Abbott Vascular - Alvimedica Medical Technologies - Arterial Remodeling Technologies - Boston Scientific Corporation - Biosensors International - Biotronik SE & Co.kG - CID S.r.l. - Clearstream Technologies Ltd. - Disa Vascular (Pty) Ltd. - Elixir Medical Corporation - Endocor Gmbh - Essen Technology (Beijing) Co., Ltd - Hexacath - Iberhospitex S.A - InspireMD, Inc. - Japan Stent Technology Co., Ltd. - Kyoto Medical - Lepu Medical Technology Co., Ltd. - Medinol - Medtronic, Inc. - Meril Life Sciences Pvt. Ltd. - Micell Technologies, Inc. - MicroPort Scientific Corporation - Minvasys - OrbusNeich - Relisys Medical Devices Limited - Reva Medical, Inc. - Sahajanand Medical Technologies - Stentys - Vascular Concepts For more information visit http://www.researchandmarkets.com/research/jf...l_coronary
BSX: 16.88 (+0.09), MDT: 72.60 (+0.55), NSPR: 1.33 (-0.07)
MediPoint: Coronary Stents - US Analysis and Market Forecasts
M2 - Thu Dec 04, 5:22AM CST
Research and Markets (http://www.researchandmarkets.com/research/xrr3sw/medipoint) has announced the addition of the "MediPoint: Coronary Stents - US Analysis and Market Forecasts" report to their offering. The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes. Each year, millions of individuals are affected by CAD worldwide. Given the high burden of the disease, it is important to develop innovative technologies that can improve outcomes and disease management. Stenting for coronary applications has been widely adopted in clinical practice worldwide, and can be used in a wide range of indications. By 2020, the coronary stents market for BMS and DES is estimated to be over $5.61 billion. Key Topics Covered: 1 List of Tables 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Products 9 Clinical Trial Analysis 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned: - Abbott Vascular - Alvimedica - Amaranth Medical - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Boston Scientific Corporation - C.R. Bard - Cardionovum - Elixir Medical Corporation - Hexacath - IRAMED - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MIV Therapeutics - Medtronic - MicroPort Scientific Corporation - Minvasys - Opto Circuits - OrbusNeich Medical - REVA Medical - Relisys Medical Devices - STENTYS - Sahajanand Medical Technologies - Terumo Corporation - Translumina - Vascular Concepts - amg International - eucatech AG For more information visit http://www.researchandmarkets.com/research/xrr3sw/medipoint
BSX: 16.88 (+0.09), MDT: 72.60 (+0.55)
MediPoint: Coronary Stents - Current and Future Players
M2 - Thu Dec 04, 4:11AM CST
Research and Markets (http://www.researchandmarkets.com/research/vrst8n/medipoint) has announced the addition of the "MediPoint: Coronary Stents - Current and Future Players" report to their offering. The global coronary stents market is a dynamic, double-digit market that is saturated with numerous players developing innovative technologies. Rapid advances in the field of interventional cardiology along with the development of minimally invasive techniques have greatly expanded the potential of therapeutic applications. Coronary stents including bare metal, drug-eluting, covered and bioabsorbable stents can be used to treat coronary artery disease, and optimize outcomes. The coronary stents market is a vast and dynamic market that is saturated with numerous players worldwide. The competitive landscape consists of large, mid-size, and small companies that have developed different types of coronary stents to target various coronary indications, such as de novo lesions, AMI, STEMI, SVD, and bifurcation lesions. The coronary stents market is largely dominated by a few key players, including Abbott Vascular, Boston Scientific, and Medtronic, followed by Biosensors International and Terumo Corporation. Scope - Investigation of current and future market competition for Coronary Stents. - Competitor assessment including device approval analysis. - Coverage of key market players and company profiles including business description, financial overview and SWOT analysis. - Strategic assessment of the device sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors using Coronary Stents in clinical practice. Key Topics Covered: 1 List of Tables 2 Introduction 3 Competitive Assessment 4 Pipeline Products 5 Current and Future Players 6 Appendix Companies Mentioned: - Abbott Vascular - Alvimedica - Amaranth Medical - Arterial Remodeling Technologies - B. Braun - Balton - Biosensors International - Biotronik - Blue Medical - Boston Scientific Corporation - C.R. Bard - Cardionovum - Elixir Medical Corporation - Hexacath - IRAMED - JW Medical Systems - Kyoto Medical Planning - Lepu Medical Technology - MIV Therapeutics - Medtronic - MicroPort Scientific Corporation - Minvasys - Opto Circuits - REVA Medical - Relisys Medical Devices - STENTYS - Sahajanand Medical Technologies - Terumo Corporation - Translumina - Vascular Concepts - amg International - eucatech AG For more information visit http://www.researchandmarkets.com/research/vrst8n/medipoint
BSX: 16.88 (+0.09), MDT: 72.60 (+0.55)
MediPoint: Aortic Stent Grafts - South America Analysis and Market Forecasts
M2 - Thu Dec 04, 4:01AM CST
Research and Markets (http://www.researchandmarkets.com/research/8b8djj/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - South America Analysis and Market Forecasts" report to their offering. Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient's native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Reasons to buy - Understand the trends shaping and driving the South America Aortic Stent Grafts market. - Realize device preferences of physicians who have performed the tests already. - Access market sizing, forecasts and quantified growth opportunities in South America Aortic Stent Grafts market through 2018. - Quantify candidate patient populations to better design product pricing & launch plans. - Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape. - Perform benchmarking analysis of growth opportunities against currently marketed products. - Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. - Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products. - Create an effective counter-strategy to gain a competitive advantage against those currently in the market. Key Topics Covered: 1 List of Tables 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned: - Altura Medical - Aptus Endosystems - B. Braun - Bolton Medical - Braile Biomedica - Cardiatis - Cook Medical - Endologix - Getinge Group - Gore Medical - Grikin Advanced Materials - Johnson & Johnson's Cordis Corporation - Jotec - LeMaitre Vascular - Lifetech Scientific - Lombard Medical - Medtronic - MicroPort Scientific Corporation - Nano Endoluminal - Terumo Corporation - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material Scitech For more information visit http://www.researchandmarkets.com/research/8b...int_aortic
JNJ: 95.37 (+0.29), MDT: 72.60 (+0.55), EVAR: 3.81 (+0.05), LMAT: 12.39 (-0.18)
MediPoint: Aortic Stent Grafts - APAC Analysis and Market Forecasts
M2 - Thu Dec 04, 3:55AM CST
Research and Markets (http://www.researchandmarkets.com/research/fxpfd4/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - APAC Analysis and Market Forecasts" report to their offering. Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient's native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Reasons to buy - Understand the trends shaping and driving the APAC Aortic Stent Grafts market. - Realize device preferences of physicians who have performed the tests already. - Access market sizing, forecasts and quantified growth opportunities in the APAC Aortic Stent Grafts market through 2018. - Quantify candidate patient populations to better design product pricing & launch plans. - Drive revenues, formulate effective sales and marketing strategies and gain in-depth understanding of the competitive landscape. - Perform benchmarking analysis of growth opportunities against currently marketed products. - Assess competitiveness of products in market by understanding the strengths and weaknesses of current competition. - Take a comprehensive look at the market's device pipeline and identify promising, paradigm-shifting products. - Create an effective counter-strategy to gain a competitive advantage against those currently in the market. - Organize your sales and marketing efforts by identifying the market categories and segments that present the best opportunities for growth. Key Topics Covered: 1 List of Tables 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned: - Altura - Aptus - B. Braun - Bolton - Braile Biomedica - Cardiatis - Cook - Endologix - Getinge - Gore - Grikin Advanced Materials - Johnson & Johnson's - Jotec - LeMaitre Vascular - Lifetech - Lombard - Medtronic - MicroPort Scientific - Nano Endoluminal - Terumo - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material For more information visit http://www.researchandmarkets.com/research/fx...int_aortic
JNJ: 95.37 (+0.29), MDT: 72.60 (+0.55), LMAT: 12.39 (-0.18)
MediPoint: Aortic Stent Grafts - US Analysis and Market Forecasts 2013-2020
M2 - Mon Nov 24, 8:35AM CST
Research and Markets (http://www.researchandmarkets.com/research/lvjkp8/medipoint_aortic) has announced the addition of the "MediPoint: Aortic Stent Grafts - US Analysis and Market Forecasts" report to their offering. Aortic stent grafts are most commonly used to reinforce a weak spot in an artery, which is known as an aneurysm. The stent grafts are designed to seal tightly with the patient's native artery above and below the aneurysm, and are used to treat abdominal aortic aneurysms as well as thoracic aortic aneurysms. Aortic aneurysms, as opposed to aneurysms found elsewhere in the body, are potentially very serious, as a burst aorta results in massive internal bleeding that can be fatal unless treated rapidly by an experienced emergency medical team. The US market is the largest market for aortic stent grafts, accounting for more than 40% of the global market. The US market is very similar to that of the global market with regard to the trends in market share. Gore Medical remains the leader in the US for both the EVAR and TEVAR markets. These three companies also offer market leading products for treating AAA and TAA, ensuring long-term, effective solutions to patients. Scope - An overview of Aortic Stent Grafts, which includes epidemiology, etiology, symptoms, diagnosis, pathology and treatment guidelines. - Annualized the US Aortic Stent Grafts market revenue and future forecasts from 2011 to 2013, forecast for 7 years to 2020. - Investigation of current and future market competition for Aortic Stent Grafts. - Insightful review of the key industry drivers, restraints and challenges as well as predicted impact of key events. - Competitor assessment including device approval analysis and device sales forecasts. - Marketed and pipeline product profiles covering efficiency, safety, clinical study details, device approvals, product positioning and device sales forecast. - Analysis of unmet needs within the market and opportunities for future players. - Technology trends evaluation to assess strength of pipeline. - An overview of all devices in development including clinical study details, design and material selection considerations, efficacy reports, and device approval timelines. - Company profiles including business description, financial overview and SWOT analysis. - Coverage of key market players. - Strategic assessment of the Aortic Stent Grafts sector through market impact analysis, future market scenario and company analysis. - Direct quotes from Key Opinion Leaders (KOL) as well as doctors Key Topics Covered: 1 Tables & Figures 2 Introduction 3 Industry Overview 4 Unmet Needs 5 Market Opportunity Analysis 6 Market Drivers, Barriers, and Substitutes 7 Competitive Assessment 8 Pipeline Assessment 9 Clinical Trials to Watch 10 Current and Future Players 11 Market Outlook 12 Appendix Companies Mentioned - Altura Medical - Aptus Endosystems - B. Braun - Bolton Medical - Braile Biom?dica - Cardiatis - Cook Medical - Endologix - Getinge Group - Gore Medical - Grikin Advanced Materials - Johnson & Johnson's Cordis Corporation - Jotec - LeMaitre Vascular - Lifetech Scientific - Lombard Medical - Medtronic - MicroPort Scientific Corporation - Nano Endoluminal - Terumo Corporation - TriVascular - Weike Medical Apparatus and Instrument - YTH Biological Material Scitech For more information visit http://www.researchandmarkets.com/research/lv...int_aortic
JNJ: 95.37 (+0.29), MDT: 72.60 (+0.55), EVAR: 3.81 (+0.05), LMAT: 12.39 (-0.18)